Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2020

View Archived Issues

GNOS-PV02 vaccine to be evaluated in patients with HCC

AI-generated compound begins phase I study in Japan for obsessive-compulsive disorder

Inovio and Beijing Advaccine collaborate to advance new vaccine against new coronavirus in China

BREEZE-AD5 phase II study of baricitinib in AD meets primary endpoint

German Medicines Agency approves phase II study of FOL-005

Kedrion Biopharma completes enrollment in phase III CARES10 study

Cerevel starts dosing volunteers in phase I study of CVL-936

First patient dosed in phase Ib study of GMI-1359 in breast cancer

FDA accepts IND application for FS-120 bispecific antibody

BBI-608 plus pembrolizumab shows encouraging antitumor activity in mCRC

Magrolimab plus cetuximab as a promising immunotherapeutic treatment regimen in CRC

Phase II study of PBI-05204 in mPDA does not meet primary endpoint

Fimbrion Therapeutics and GlaxoSmithKline describe Escherichia coli FimH inhibitors

New high affinity nerve growth factor receptor inhibitors identified at Medshine Discovery

Naltrexone prodrugs synthesized at Alkermes

Novartis patents compounds for IKZF2-dependent disease

Recordati Industria Chimica e Farmaceutica discovers P2X3 and P2X2/3 antagonists

"Confused and disorganized": Stress, identity crises part of growing up -- for organoids

RC-48-ADC shows meaningful benefit in phase I solid tumors trial

CEACAM6 levels linked to sensitivity to pelareorep in pancreatic adenocarcinoma

IRICoR, UdeM and Medigene establish collaboration on novel cancer antigens

Phase I study of Rani's orally delivered octreotide meets primary and secondary endpoints

Fuzionaire Diagnostics establishes new research collaboration in neurodegeneration

IND clearance for VistaGen's AV-101 for levodopa-induced dyskinesia in Parkinson's

Immune Response BioPharma plans IND filing for new SARS/coronavirus vaccine

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...